Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The salted artery and angiotensin II signaling: a deadly duo in arterial disease.

Wang M, Lakatta EG.

J Hypertens. 2009 Jan;27(1):19-21. doi: 10.1097/HJH.0b013e32831d1fed. No abstract available.

2.

High-salt diet combined with elevated angiotensin II accelerates atherosclerosis in apolipoprotein E-deficient mice.

Johansson ME, Bernberg E, Andersson IJ, Bie P, Skøtt O, Gan LM, Bergström G.

J Hypertens. 2009 Jan;27(1):41-7.

PMID:
19145766
3.

cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.

Ushio-Fukai M, Zuo L, Ikeda S, Tojo T, Patrushev NA, Alexander RW.

Circ Res. 2005 Oct 14;97(8):829-36. Epub 2005 Sep 8. Retraction in: Circ Res. 2010 Jun 11;106(11):1784.

4.

The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis.

McAllister-Lucas LM, Jin X, Gu S, Siu K, McDonnell S, Ruland J, Delekta PC, Van Beek M, Lucas PC.

J Biol Chem. 2010 Aug 20;285(34):25880-4. doi: 10.1074/jbc.C110.109421. Epub 2010 Jul 5.

5.

Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension.

Carrillo-Sepulveda MA, Keen HL, Davis DR, Grobe JL, Sigmund CD.

PLoS One. 2014 Aug 14;9(8):e103786. doi: 10.1371/journal.pone.0103786. eCollection 2014.

6.

Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle.

Ushio-Fukai M, Alexander RW.

Hypertension. 2006 Nov;48(5):797-803. Epub 2006 Oct 2. Review. No abstract available.

7.

Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.

Valente AJ, Yoshida T, Murthy SN, Sakamuri SS, Katsuyama M, Clark RA, Delafontaine P, Chandrasekar B.

Am J Physiol Heart Circ Physiol. 2012 Aug 1;303(3):H282-96. doi: 10.1152/ajpheart.00231.2012. Epub 2012 May 25.

8.

Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.

Sahara M, Ikutomi M, Morita T, Minami Y, Nakajima T, Hirata Y, Nagai R, Sata M.

Cardiovasc Res. 2014 Feb 1;101(2):236-46. doi: 10.1093/cvr/cvt245. Epub 2013 Nov 4.

PMID:
24193738
10.

Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells.

Sanada F, Taniyama Y, Iekushi K, Azuma J, Okayama K, Kusunoki H, Koibuchi N, Doi T, Aizawa Y, Morishita R.

Circ Res. 2009 Sep 25;105(7):667-75, 13 p following 675. doi: 10.1161/CIRCRESAHA.109.202713. Epub 2009 Aug 27.

11.
12.

Olmesartan inhibits angiotensin II-Induced migration of vascular smooth muscle cells through Src and mitogen-activated protein kinase pathways.

Kyotani Y, Zhao J, Tomita S, Nakayama H, Isosaki M, Uno M, Yoshizumi M.

J Pharmacol Sci. 2010;113(2):161-8. Epub 2010 May 28.

13.

Angiotensin II signal transduction and the mitogen-activated protein kinase pathway.

Duff JL, Marrero MB, Paxton WG, Schieffer B, Bernstein KE, Berk BC.

Cardiovasc Res. 1995 Oct;30(4):511-7. Review.

PMID:
8574999
14.
15.

Hyperplastic vascular smooth muscle cells of the intrarenal arteries in angiotensin II type 1a receptor null mutant mice.

Inokuchi S, Kimura K, Sugaya T, Inokuchi K, Murakami K, Sakai T.

Kidney Int. 2001 Aug;60(2):722-31.

16.

Angiotensin II type 1 receptor-associated protein is an endogenous inhibitor of angiotensin II type 1 receptor action in cardiac hypertrophy: role in check and balance.

Zhang Z, Dzau VJ.

Hypertension. 2010 May;55(5):1086-7. doi: 10.1161/HYPERTENSIONAHA.110.150458. Epub 2010 Mar 15. No abstract available.

17.

TMEM16A contributes to angiotensin II-induced cerebral vasoconstriction via the RhoA/ROCK signaling pathway.

Li RS, Wang Y, Chen HS, Jiang FY, Tu Q, Li WJ, Yin RX.

Mol Med Rep. 2016 Apr;13(4):3691-9. doi: 10.3892/mmr.2016.4979. Epub 2016 Mar 4.

PMID:
26955761
18.

Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.

Sendra J, Llorente-Cortés V, Costales P, Huesca-Gómez C, Badimon L.

Cardiovasc Res. 2008 Jun 1;78(3):581-9. doi: 10.1093/cvr/cvn043. Epub 2008 Feb 15.

PMID:
18281370
19.

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

Mehta PK, Griendling KK.

Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97. Epub 2006 Jul 26. Review.

20.

Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.

Tabet F, Schiffrin EL, Callera GE, He Y, Yao G, Ostman A, Kappert K, Tonks NK, Touyz RM.

Circ Res. 2008 Jul 18;103(2):149-58. doi: 10.1161/CIRCRESAHA.108.178608. Epub 2008 Jun 19.

Supplemental Content

Support Center